Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
International Journal of Hematology|August 28, 2013
WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study GroupHirozumi Sano, Akira Shimada, Ken Tabuchi, et al.Blood|November 9, 2007
Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemiaYoshiyuki Kosaka, Hiroshi Yagasaki, Kimihiko Sano, et al.Clinical Genitourinary Cancer|September 13, 2024
Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score MatchingKeita Kobayashi, Hiroaki Matsumoto, Shigeru Sakano, et al.Japanese Journal of Clinical Oncology|October 7, 2024
Prognostic risk score and index including the platelet-to-lymphocyte ratio and lactate dehydrogenase in patients with metastatic or unresectable urothelial carcinoma treated with immune checkpoint inhibitorsKeita Kobayashi, Shigeru Sakano, Hiroaki Matsumoto, et al.Transplantation|December 20, 2002
Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation modelLuis A Fernandez, Jose Torrealba, Gökhan Yagci, et al.Genes, Chromosomes & Cancer|May 1, 2013
NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemiaNorio Shiba, Hitoshi Ichikawa, Tomohiko Taki, et al.Leukemia Research and Treatment|January 4, 2014
Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid MalignanciesHiroko Fukushima, Takashi Fukushima, Aiko Sakai, et al.Human Cell|July 30, 2024
Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumorKeisuke Kato, Jun-Ichi Nagai, Hiroaki Goto, et al.Journal of Human Genetics|May 20, 2016
Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool ageHisato Suzuki, Hiroko Fukushima, Ryoko Suzuki, et al.International Journal of Hematology|February 3, 2011
Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study GroupHiroaki Goto, Takeshi Inukai, Hiroyasu Inoue, et al.Pageof 10